Retinal Diseases: Clinical Trials

3,611 trials for Retinal Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1999 completed, 572 unknown, 344 recruiting, 283 terminated. 880 Not applicable, 737 Phase 2, 460 Phase 1, 434 Phase 3, 253 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable880Completed 453, Unknown 180, Recruiting 98, Terminated 51, Not yet recruiting 35, Withdrawn 31, Active not recruiting 23, Enrolling by invitation 8, Suspended 1
Phase 2737Completed 392, Unknown 93, Terminated 91, Recruiting 64, Active not recruiting 46, Withdrawn 31, Not yet recruiting 16, Enrolling by invitation 4
Phase 1460Completed 256, Recruiting 55, Unknown 51, Terminated 41, Active not recruiting 32, Withdrawn 12, Not yet recruiting 10, Enrolling by invitation 2, Suspended 1
Phase 3434Completed 256, Unknown 56, Terminated 50, Recruiting 22, Active not recruiting 18, Not yet recruiting 15, Withdrawn 15, Enrolling by invitation 1, Suspended 1
Phase 4253Completed 154, Unknown 48, Terminated 22, Recruiting 9, Withdrawn 9, Not yet recruiting 7, Active not recruiting 2, Enrolling by invitation 2
Early Phase 144Completed 13, Recruiting 12, Unknown 9, Not yet recruiting 4, Active not recruiting 2, Terminated 2, Enrolling by invitation 1, Withdrawn 1

Follow Retinal Diseases: new trials by email Literature Review of Retinal Diseases trials Research Report on Retinal Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Remapping Text in Sentence and Word Tasks to Aid Reading With Central Vision Loss
Personalised Remapping Training, RSVP personalized remappi, Reading text in the wild with remapping - Macular Degeneration, Central Visual Impairment
Not applicableNot yet recruitingUniversity of Minnesota2162027-06-012026-10-29
Eye Health Intervention Study in Upper Manhattan
Intervention, Usual Care - Glaucoma, Suspect, Diabetic Retinopathy
Not applicableWithdrawnColumbia University2027-04-012026-05-29
Safety and Clinical Performance of the LENTIS® MAX LS-313 MF80 Compared With the Monofocal L-313 in Cataract Patients With Late Age-Related Macular Degeneration: A Multicenter Comparative Clinical Investigation.
Intraocular Lens - Cataract, AMD - Age-Related Macular Degeneration
Not applicableNot yet recruitingTeleon Surgical B.V.352027-02-012026-11-04
Non-invasive Ultrasound Retinal Stimulation for Vision Restoration
Non-invasive ultrasound retinal stimulation Device - Age-Related Macular Degeneration, Retinitis Pigmentosa
Not applicableNot yet recruitingUniversity of Southern California52027-01-102026-01-08
MIND-AMD Study: a Multidisciplinary Investigation of Neuroretinal Damage in Age-related Macular Degeneration.
Age-Related (Dry) Macular Degeneration, Age-Related Macular Degeneration (AMD)
Not yet recruitingIRCCS San Raffaele1602027-01-022026-09-29
Prevalence of Age-Related Macular Degeneration in Assiut University Hospitals
OCT - clear - Age-Related Macular Degeneration (AMD)
Not yet recruitingAssiut University902027-01-012026-10-21
The GEIR (Grupo español de Ictus Retina) Registry: Rationale and Design of the First Nationwide Multicentre Retinal Stroke Registry in Spain
Retinal Artery Occlusion, Central Retinal Artery Occlusion
Not yet recruitingGermans Trias i Pujol Hospital5002027-01-012026-11-06
Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants
Cord Blood Red Blood Cells, Standard Adult Donor Red Blood Cells - Extremely Premature Infant, Anemia Neonatal
Not applicableNot yet recruitingHospital Clinic of Barcelona2802027-01-012026-11-09
Efficacy of Aflibercept With Sequential Laser Photocoagulation for Macular Edema Secondary to Retinal Artery Macroaneurysm.
evaluate the efficacy and safety of a sequential treatment protocol-comprising three consecutive monthly intravitreal injections of aflibercept 8 mg followed by focal laser photocoagulation targeted a - Retinal Arterial Macroaneurysm
Not yet recruitingNew Valley University152027-01-012026-11-10
Retinopathy of Prematurity - Visual Function and Retinal Structure
Retinopathy of Prematurity (ROP), Prematurity Complications
Not yet recruitingOslo University Hospital1402027-01-012026-11-10
24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome
N-acetylcysteine amide, Placebo - Retinitis Pigmentosa (RP), Usher Syndrome
Phase 3Not yet recruitingNacuity Pharmaceuticals, Inc.802026-12-012026-07-01
Faricimab for Chronic Central Serous Chorioretinopathy: A Randomized Sham-Controlled Trial
Faricimab, Sham - Central Serous Chorioretinopathy (CSC)
Phase 2Not yet recruitingSingapore National Eye Centre502026-12-012026-07-02
The Safety and Efficacy of Intravitreal Topotecan for the Treatment of Proliferative Vitreoretinopathy
Topotecan - Proliferative Vitreoretinopathy, Proliferative Vitreo-Retinopathy
Phase 1Not yet recruitingMassachusetts Eye and Ear Infirmary502026-12-012026-10-16
Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care
Ultra-widefield Optical Coherence Tomography (UWF-OCT), Wide-field ophthalmic imaging system - Retinopathy of Prematurity (ROP)
Not applicableRecruitingDuke University1752026-12-012026-09-17
Morpho-functional Evaluation of the Retina and Choroid Using Multimodal Imaging in Healthy Subjects and Patients With Retino-choroidal Diseases
Retinal Diseases, Choroidal Diseases
Not yet recruitingFondazione G.B. Bietti, IRCCS1252026-12-012026-11-12
Intensive Glycemic Control Combined With Brolucizumab for Diabetic Macular Edema
Intensive Glycemic Management, Brolucizumab - Diabetic Macular Edema, Diabetic Retinopathy
Not applicableNot yet recruitingThe Fourth Affiliated Hospital of Zhejiang University School of Medicine1002026-11-302026-11-13
Adaptive Optics Scanning Light Ophthalmoscopy (AOSLO) and Microperimetry (MP) Sub-study
Adaptive Optics Scanning Light Ophthalmoscopy, Microperimetry, Optical Coherence Tomography - Geographic Atrophy
Not applicableEnrolling by invitationUniversity of Wisconsin, Madison102026-11-052026-10-26
MacuMira Microcurrent Stimulation for Dark Adaptation in Dry Age-Related Macular Degeneration
Transpalpebral microcurrent electrical stimulation - Age-Related Macular Degeneration (AMD)
Not applicableNot yet recruitingClarity Eye Institute502026-11-042026-11-04
A Phase 1, First-in-Human Study of CITY-RBP4 in Healthy Volunteers and STGD1 Participants
CITY-RBP4, Placebo - Stargardt Disease 1, STGD1
Phase 1RecruitingCity Therapeutics482026-11-042026-11-12
OCT Macula Biomarkers Before Silicone Oil Removal and Visual Outcome After Silicone Oil Removal
Retinal Detachment, Macular Edema
Not yet recruitingAssiut University302026-11-012026-10-08

Showing 20 of 3611. Sign in to see all of them.

Narrower conditions

Macular Degeneration (1174)  ·  Diabetic Retinopathy (685)  ·  Macular Edema (418)  ·  Retinal Vein Occlusion (276)  ·  Retinitis Pigmentosa (268)  ·  Diabetes Mellitus (199)  ·  Geographic Atrophy (179)  ·  Retinopathy of Prematurity (167)  ·  Retinal Detachment (162)  ·  Choroidal Neovascularization (153)  ·  Eye Diseases (138)  ·  Retinal Perforations (137)  ·  Retinal Degeneration (130)  ·  Epiretinal Membrane (123)

Broader conditions

Eye Diseases (3473)  ·  Retinal Degeneration (1886)  ·  Cardiovascular Diseases (1021)  ·  Vascular Diseases (1013)  ·  Endocrine System Diseases (769)  ·  Diabetic Angiopathies (681)  ·  Diabetes Complications (675)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (640)  ·  Pathological Conditions, Signs and Symptoms (574)  ·  Eye Diseases, Hereditary (560)  ·  Diabetes Mellitus (556)  ·  Macular Degeneration (527)  ·  Genetic Diseases, Inborn (461)  ·  Nervous System Diseases (354)

Interventions

Ranibizumab (336)  ·  aflibercept (206)  ·  Bevacizumab (126)  ·  salicylhydroxamic acid (79)  ·  Dexamethasone (61)  ·  Calcium Dobesilate (54)  ·  Triamcinolone Acetonide (51)  ·  Vitrectomy (49)  ·  Tomography, Optical Coherence (42)  ·  Verteporfin (34)  ·  pegaptanib (29)  ·  Ganciclovir (27)  ·  Carboplatin (26)  ·  brolucizumab (26)  ·  Intravitreal Injections (24)

Sponsors

National Eye Institute (NEI) (121)  ·  Novartis Pharmaceuticals (79)  ·  Bayer (53)  ·  Medical University of Vienna (41)  ·  Allergan (39)  ·  Johns Hopkins University (32)  ·  Sun Yat-sen University (32)  ·  Hoffmann-La Roche (30)  ·  Shahid Beheshti University of Medical Sciences (27)  ·  Genentech, Inc. (26)  ·  Alcon Research (25)  ·  Asociación para Evitar la Ceguera en México (25)  ·  Duke University (25)  ·  Association for Innovation and Biomedical Research on Light and Image (24)  ·  University of Sao Paulo (24)

Countries

United States (1425)  ·  France (283)  ·  China (260)  ·  United Kingdom (251)  ·  Germany (240)  ·  Canada (211)  ·  Italy (189)  ·  Austria (151)  ·  Australia (142)  ·  Spain (136)  ·  Israel (117)  ·  South Korea (106)  ·  Switzerland (94)  ·  Brazil (89)  ·  Netherlands (85)

Top investigators

Emily Y Chew, M.D. (11)  ·  Hamid Ahmadieh, MD (11)  ·  Peter A Campochiaro, MD (10)  ·  Hugo Quiroz-Mercado, MD (9)  ·  Pablo Velazquez-Martin, MD (9)  ·  Jason Hsu, MD (8)  ·  Cynthia A Toth, MD (7)

Results publications

PMID 37314061, PMID 40522203, PMID 37702300, PMID 32408387, PMID 32374423, PMID 32573764, PMID 36912792, PMID 40547876, PMID 22281388, PMID 23049090, PMID 25458728, PMID 26089210, PMID 30957581, PMID 32844399, PMID 34934034, PMID 39758130, PMID 21571677, PMID 23084240, PMID 23706949, PMID 24768239, PMID 25439614, PMID 25677668, PMID 30194931, PMID 31042791, PMID 32633861, PMID 33206392, PMID 33331670, PMID 35085502, PMID 36246941, PMID 36774994, PMID 37260074, PMID 37261916, PMID 38254722, PMID 39102242, PMID 39207600, PMID 11297486, PMID 15808240, PMID 17021318, PMID 17021319, PMID 18441312, PMID 19255158, PMID 19365036, PMID 19506188, PMID 19953081, PMID 20008710, PMID 20189654, PMID 20378094, PMID 20427088, PMID 20580421, PMID 20683380

NIH funding

2014 (18), 2019 (17), 2018 (14), U10EY014231 (9), 2017 (8), U10EY018817 (8), 2009 (7), 2016 (7), 2025 (7), 2015 (6), U10EY014229 (6), U10HD021385 (5), U10HD027851 (5), U10HD027853 (5), U10HD027856 (5)